See the impact of ENTYVIO (vedolizumab) in reducing symptoms and achieving remission for Crohn’s disease. See Safety and Prescribing Information.

How Does Entyvio Work? Ulcerative colitis and Crohn’s disease are types of inflammatory bowel disease (IBD) that cause irritation and inflammation in the gastrointestinal tract (GI tract).

Oct 10, 2024 · Entyvio (vedolizumab) is a prescription medication used to treat ulcerative colitis (UC) and Crohn’s disease. Learn about side effects, warnings, and dosage.

Nov 28, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) in adults. Entyvio infusion is administered intravenously for the first two doses, followed …

WHEN YOU NEED HELP, ENTYVIOCONNECT IS HERE FOR YOU Living with moderate to severe ulcerative colitis or Crohn’s disease can be difficult enough. Managing your treatment shouldn’t be. …

Vedolizumab (brand name: Entyvio®) is a medication used to treat Crohn’s disease and ulcerative colitis. It is an antibody that prevents inflammation causing white blood cells from entering and …

An allergic reaction can happen during or after the infusion (rash; itching; swelling of lips, tongue, throat or face; shortness of breath; heart palpitations), there have been reports of infections, and liver …

Apr 15, 2025 · This further established Entyvio’s role as a reliable medication in the management of Crohn disease. These strong clinical findings support the inclusion of Entyvio treatm ent in guidelines …

Nov 21, 2025 · Entyvio (vedolizumab) is a prescription drug used to treat Crohn’s disease and ulcerative colitis. Its mechanism of action (how it works) is to block specific inflammatory cells from entering ...

May 16, 2024 · Entyvio (generic name: vedolizumab) is a biologic therapy approved for the treatment of ulcerative colitis and Crohn’s disease. Entyvio has no known systemic (whole body) …